(Q44844852)

6 December 2017

Nonenzymatic glycation at the N terminus of pathogenic prion protein in transmissible spongiform encephalopathies (English)

1 reference

6 December 2017

0 references

7

Richard J Kascsak

1 reference

6 December 2017

8

Richard I Carp

1 reference

6 December 2017

Yeong-Gon Choi

1

1 reference

6 December 2017

Jae-Il Kim

2

1 reference

6 December 2017

Yong-Chul Jeon

3

1 reference

6 December 2017

Seok-Joo Park

4

1 reference

6 December 2017

Eun-Kyoung Choi

5

1 reference

6 December 2017

Richard Rubenstein

6

1 reference

6 December 2017

Yong-Sun Kim

9

1 reference

6 December 2017

language of work or name

English

0 references

publication date

14 April 2004

1 reference

Journal of Biological Chemistry

6 December 2017

1 reference

6 December 2017

279

1 reference

6 December 2017

29

1 reference

6 December 2017

30402-30409

1 reference

Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding

6 December 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Advanced protein glycosylation in diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Protein glycation, diabetes, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Evidence for non-enzymatic glycosylation in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Glycation and Post-translational Processing of Human Interferon-γ Expressed in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Radical AGEing in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Immunodiagnosis of prion disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Novel differences between two human prion strains revealed by two-dimensional gel electrophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Transgenic and knockout mice in research on prion diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Characterization of antibody affinities using an AGE-modified dipeptide spot library

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Scrapie-associated prion protein accumulates in astrocytes during scrapie infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

Strain-specific prion-protein conformation determined by metal ions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400854200

21 January 2018

Identifiers

DOI

10.1074/JBC.M400854200

1 reference

6 December 2017

1 reference